171 related articles for article (PubMed ID: 34237057)
1. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
Kharin L; Bychkov I; Karnaukhov N; Voloshin M; Fazliyeva R; Deneka A; Frantsiyants E; Kit O; Golemis E; Boumber Y
PLoS One; 2021; 16(7):e0252132. PubMed ID: 34237057
[TBL] [Abstract][Full Text] [Related]
2. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
Topchu I; Karnaukhov N; Mazitova A; Yugai V; Voloshin M; Tikhomirova M; Kit O; Frantsiyants E; Kharin L; Airapetova T; Ratner E; Sabirov A; Abramova Z; Serebriiskii I; Boumber Y; Deneka A
J Thorac Dis; 2021 Mar; 13(3):1370-1379. PubMed ID: 33841930
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
5. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation.
Meng X; Peng X; Ouyang W; Li H; Na R; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Zhuang G; Tang H; Peng Z
Biol Proced Online; 2023 Dec; 25(1):32. PubMed ID: 38041016
[TBL] [Abstract][Full Text] [Related]
6. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract][Full Text] [Related]
7. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Kudinov AE; Deneka A; Nikonova AS; Beck TN; Ahn YH; Liu X; Martinez CF; Schultz FA; Reynolds S; Yang DH; Cai KQ; Yaghmour KM; Baker KA; Egleston BL; Nicolas E; Chikwem A; Andrianov G; Singh S; Borghaei H; Serebriiskii IG; Gibbons DL; Kurie JM; Golemis EA; Boumber Y
Proc Natl Acad Sci U S A; 2016 Jun; 113(25):6955-60. PubMed ID: 27274057
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia.
Zhao HZ; Jia M; Luo ZB; Cheng YP; Xu XJ; Zhang JY; Li SS; Tang YM
Neoplasma; 2016; 63(1):150-7. PubMed ID: 26639245
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Analysis Revealed a Correlation between Musashi-2 and Cyclin-D1 Expression in Patients with Oral Squamous Cells Carcinoma.
Troiano G; Caponio VCA; Botti G; Aquino G; Losito NS; Pedicillo MC; Zhurakivska K; Arena C; Ciavarella D; Mastrangelo F; Lo Russo L; Lo Muzio L; Pannone G
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878037
[TBL] [Abstract][Full Text] [Related]
10. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
Yang H; Hu J; Chen J; Chen Z; Jiao F; Cui J; Quan M; Wang L
Med Oncol; 2020 Aug; 37(9):84. PubMed ID: 32780197
[TBL] [Abstract][Full Text] [Related]
12. Musashi-2 is a prognostic marker for the survival of patients with cervical cancer.
Liu Y; Fan Y; Wang X; Huang Z; Shi K; Zhou B
Oncol Lett; 2018 Apr; 15(4):5425-5432. PubMed ID: 29556294
[TBL] [Abstract][Full Text] [Related]
13. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract][Full Text] [Related]
14. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
15. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
[TBL] [Abstract][Full Text] [Related]
16. Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
[TBL] [Abstract][Full Text] [Related]
17. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
18. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
[TBL] [Abstract][Full Text] [Related]
19. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
[TBL] [Abstract][Full Text] [Related]
20. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
